Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04214301 · ClinicalTrials.gov registry record · Phase 4
An Open-Label Preference Evaluation of BLI800
A Phase 4 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT04214301: Completed Phase 4 study, sponsored by Braintree Laboratories.
NCT04214301 is a Phase 4 study that has completed, run by Braintree Laboratories. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04214301, a Phase 4 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate patient experience ratings of BLI800 in adult patients undergoing colonoscopy.
Primary Outcome
Question: How easy or difficult was it to consume the study preparation?
Interventions
- DRUG BLI800
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-09-24 |
| Est. Completion | 2019-11-21 |
| Phase | Phase 4 |
What the finished NCT04214301 record still lists
NCT04214301 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which BLI800 is the first listed.
NCT04214301 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04214301 about?
NCT04214301 is a clinical study titled "An Open-Label Preference Evaluation of BLI800". The purpose of this study is to evaluate patient experience ratings of BLI800 in adult patients undergoing colonoscopy.
What is the current status of trial NCT04214301?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2019-09-24. Estimated completion is 2019-11-21.
What interventions are being tested in trial NCT04214301?
The interventions under investigation include: BLI800 (DRUG).
Who is sponsoring clinical trial NCT04214301?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04214301's enrollment target sits among peer trials
40 1397th of 2000 higher than 533 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI